Immunotherapy in metastatic melanoma: a novel scenario of new toxicities and their management

Checkpoint inhibitors can cause an imbalance in immune tolerance that may clinically manifest as immune-related adverse events (irAEs). These events may involve many organs and tissues, including the skin, gastrointestinal (GI) tract, liver, endocrine system, kidneys, central nervous system (CNS), e...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Melanoma Manag
Egile Nagusiak: Simeone, Ester, Grimaldi, Antonio M, Festino, Lucia, Trojaniello, Claudia, Vitale, Maria G, Vanella, Vito, Palla, Marco, Ascierto, Paolo A
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Future Medicine Ltd 2019
Gaiak:
Review
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6920742/
https://ncbi.nlm.nih.gov/pubmed/31871619
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/mmt-2019-0005
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak